At Work With: Martin O'Brien

Martin O'Brien
Martin O'Brien

MARTIN O'BRIEN
Partner, Rosetta

What was your biggest break?
My first agency position out of college was as the assistant to the CEO. Having a front row view proved very advantageous in understanding what a leadership position required.

What's the best and/or worst part of your job?
The best part of my job is coming up with innovative launch strategies. The worst part is losing a client you are heavily invested in.

How long is a typical meeting with clients?
I spend a lot of time with clients in brainstorming or planning meetings, which typically are 2-3 hours long.

Where did you go to college? Did it help you prepare for your career?
I went to Hobart & William Smith Colleges. They focused on critical thinking and writing, both of which have been invaluable in my career.

What was your greatest professional challenge?
Balancing work and family life.

What books are you reading?
I read an article recently about The Revolt of the Masses, a 1929 book by José Ortega y Gasset. The article declared it the smartest thing written about the modern digital age. I am checking it out.

You must be a registered member of MMM to post a comment.
close

Next Article in Careers

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.